0 results

Patient Corner

Anatomical Illustrations

More

Last reference updates

  • Sep 23, 2016 - MedWatch Drug Updates

Recall of sterile products by Wells Pharmacy due to concern over a lack of sterility assurance

Wells Pharmacy issued a recalled against sterile products due to lack of sterility assurance

Read more
  • Aug 31, 2016 - FDA Drug Updates

FDA approved Erelzi (etanercept-szzs), a biosimilar to Enbrel

FDA approved Erelzi (etanercept-szzs), a biosimilar to Enbrel for multiple inflammatory diseases

Read more
  • Aug 26, 2016 - MedWatch Drug Updates

Programmable Syringe Pumps: lack of fluid continuity at low infusion rates

Lack of flow continuity rates associated with the use of programmable syringe pumps may cause serious adverse events

Read more
  • Sep 12, 2016 - MedWatch Drug Updates

Recall of GlucaGen HypoKit (glucagon [rDNA origin] for injection) by Novo Nordisk Inc.

Six batches of the GlucaGen HypoKit is being recalled due to complaints of detached needles on the syringe

Read more
  • Aug 16, 2016 - MedWatch Drug Updates

Recall of Roadrunner UniGlide Hydrophilic Wire Guides by Cook Medical due to raw material issue

Cook Medical has recalled Roadrunner Uniglide Hydrophilic Wire Guide because of issue with raw material

Read more
  • May 19, 2016 - FDA Drug Updates

FDA approves Tecentriq (atezolizumab) for treatment of urothelial carcinoma

FDA approved Tecentriq (atezolizumab), a PD-1/PD-L1 inhibitors for treatment of the most common type of bladder cancer, called urothelial carcinoma

Read more
  • May 5, 2016 - MedWatch Drug Updates

Class I Recall of Dialog+ Hemodialysis System by B. Braun Medical due to defective conductivity sensors

B. Braun Medical recalled the Dialog+ Hemodialysis System due to cracks in conductivity sensors that may allow air to enter into the dialysis fluid and lead to improper blood filtration

Read more
  • May 3, 2016 - FDA Drug Updates

FDA approved Nuplazid (pimavanserin) for Parkinson’s disease psychosis

FDA approved Nuplazid (pimavanserin) for hallucinations and delusions associated with Parkinson’s disease

Read more
  • Jul 29, 2016 - MedWatch Drug Updates

Class I Recall of AVEA Ventilator by CareFusion- Electrical issue may cause unexpected shutdown

CareFusion has recalled AVEA Ventilator because of electrical issue that may shut down the ventilator unexpectedly

Read more
  • Jul 29, 2016 - FDA Drug Updates

FDA approves Adlyxin (lixisenatide) for Type 2 Diabetes

FDA approved Adlyxin (lixisenatide) injection to improve glycemic control in adults with type 2 diabetes

Read more